Janosch Ortmann

The paper introduces KuLGaP, a selective measure to assess therapy response in patient-derived xenografts by comparing treatment and control arms, improving accuracy over existing methods.

The paper develops Xeva, an open-source tool for analyzing PDX pharmacogenomic data, finding that few genes and pathways show passage-specific changes.